SUMMARY The most sensitive nonradiometrlc routine assay for angiotensin-converting enzyme (ACE) activity uses ft uorometry to detect His-Leu released from Hip-His-Leu. Our results indicate that, in contrast to human serum, rat serum and plasma contain large and variable amounts of dipeptidase activity that lead to a subestimation of the ACE activity measured in 0.1 M potassium phosphate buffer, pH 8.3, containing 0.3 M NaCl, the most commonly used assay for '1uman serum and tissue ACE. We describe and validate an assay for 1 to 10 µL rat and human serum or plasma using 5 mM Hip-His-Leu in 500 µL of 0.4 M sodium borate buffer, pH 8.3, containing 0.9 M NaCl at 37°C that reduced the subestimation error to :5 3% (rat serum) and :5 0.1 % (human serum) and increased the ACE activity twofold to threefold. The K,,, and V mu are reported for rat serum ACE (Hip-His-Leu) and dipeptidase (His-Leu) in borate buffer and phosphate buffer. Rat serum ACE hydrolysis of Hip-His-Leu measured by ft uorometry correlated (r = 0.99, p < 0.05) with the hydroly sis of angiotensin I measured by high-performance liquid chromatography. A direct method based on amino acid analysis is described for evaluating the dipeptidase error of complex mixtures such as tissue extracts and other physiological fluids. We have found that the assay can be used to measure ACE activity in 25 samples (in duplicate) in 2 hours with small intraassa y (2.2 % ) and interassa y (3.9%) coefficients of variation. It appears to be suitable for serial measurements in smal l animals in studies of the renin-angiotensin system in experimental hypertension and other physiopathological conditions. (Hypertension 7: 244-252, 1985) KEY Woaos • rat angiotensin-converting enzyme • rat serum conversion of angiotensin I • rat dipeptidase activity • ftuorometric converting-enzyme assay • renin-angiotensin system R ENIN and angiotensin-converting enzyme (ACE) release the vasoconstrictor peptide an giotensin II (ANG II) from the precursor pro tein angiotensinogen by sequential, specific limited proteolysis reactions. Renin and ACE have a diffuse
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ENIN and angiotensin-converting enzyme (ACE) release the vasoconstrictor peptide an giotensin II (ANG II) from the precursor pro tein angiotensinogen by sequential, specific limited proteolysis reactions. Renin and ACE have a diffuse distribution in the bcxly and have been detected in vascular beds, blood, and many tissues including kid ney and brain.1• 2 Although it is generally believed that the ACE present in pulmonary endothelial cells plays a major role in the conversion of angiotensin I (ANG I) to ANG II, extrapulmonary vascular and tissue ACE also may be functionally important. 1 -3 Oparil and colleagues4 have suggested that plasma ACE activity may reflect pulmonary conversion and can be altered by pulmonary disease, for which both highol--{, and lo\0 levels of plasma ACE activity have been reported. Levels of plasma ACE increase in re sponse to long-term blockade of ACE activity by cap topril7 or MK-4218 in parallel to the increase also ob served in levels of lung ACE, which indicates that changes of plasma ACE activity can reflect perturba tions of the renin-angiotensin system.
Hip-His-Leu and, to a lesser extent, Hip-Gly-Gly are the NH 2 -protected tripeptide substrates used most frequently to measure ACE activity in blood, tissue extracts, and purified enzyme preparations. 2· 6 The most commonly used routine serum assay employs Hip-His-Leu in 0. I M potassium phosphate buffer, pH 8.3, containing 0.3 M NaCl (PB) and the spectropho-tometric determination of hippuric acid after extraction into ethyl acetate. 9 Friedland and Silverstein 1 0 adapted this assay for the fluorometric determination of human serum ACE, which is the most sensitive nonradiomet ric detection method available, and also provided indi rect evidence showing that human serum dipeptidase activity is sufficiently low so as not to interfere with the assay.
When we attempted to use this fluorometric method for serial measurements of rat serum and plasma ACE activity we found that the rat serum and plasma dipep tidase activity were high enough to substantially inter fere with the assay. This paper describes our solution to the problem of dipeptidase interference: we used a 0.4 M sodium borate buffer, pH 8.3, containing 0.9 M NaCl (BB) to inhibit dipeptidase activity. This buffer also increased human and rat ACE activity 2.3-fold and threefold respectively. We found that the assay conditions proposed can be used for the measurement of ACE in as little as 1 µL of rat serum or plasma for serial determinations in experimental models of hyper tension or other pathophysiological states. Some of the data have been reported previously.11
Materials and Methods
Hip-His-Leu, His-Leu, ANG I, and ANG II were synthesized by Professors L. Juliano and A.C.M. Paiva, Escola Paulista de Medicina, Sao Paulo, Brazil, and were homogeneous by the criteria of amino acid composition, high-voltage paper electrophoresis, and thin-layer chromatography. The bradykinin-potentiat ing peptides (BPP), BPP51 (SQ 20,475), <Glu-Lys Trp-Ala-Pro, 1 2 and BPP.,. (SQ 20,881), <Glu-Trp Pro-Arg-Pro-Gln-Ile-Pro-Pro, 12· 1 3 were purchased from SchwarzJMann, Orangeburg, New York. The amino acid composition and concentration of each peptide were determined by amino acid analysis after acid hydrolysis with HCl at l l0°C for 22 hours. Chemicals and amino acid standards used for the amino acid analyzer and trifluoroacetic acid were products of Pierce Chemical Company, Rockford, Illinois. The o-phthaldialdehyde was purchased from Sigma Chemical Company, St. Louis, Missouri. Methanol (Lichrosolv grade) was ob tained from Merck & Co., Inc., Rahway, New Jersey.
All other chemicals were reagent grade or equivalent. All glassware was siliconized.
Serum
Blood was collected into glass tubes from normoten sive male Wistar rats (200-250 g) by decapitation, and serum was separated after 2 hours at 37°C. Aliquots (500 µL) were transferred to siliconized glass tubes and used immediately or stored at -22°C. Rat plasma was separated from blood collected in tubes precoated with heparin. Human serum was prepared in the same manner from blood obtained by venous puncture of the arm.
Angiotensin-Converting Enzyme

Solutions
One liter of a 1.25-fold concentrated buffer solution (0.5 M sodium borate buffer, pH 8.3, containing 1.125 M NaCl) was prepared with 30.5 g of H3B04 and 65. 7 g of NaCl, adjusted to pH 8.30 with 13 N NaOH, and stored at room temperature for up to 1 month. The stock substrate solution, 25 mM Hip-His-Leu, was prepared by dissolving 448 mg in 40 ml of 25 mM NaOH and was stored at -22°C. The concentration of Hip-His-Leu was determined by amino acid analysis and adjusted to 25 mM if necessary. The assay solution was prepared by mixing 4 volumes of 1.25-fold con centrated buffer with 1 volume of substrate, with the pH checked at 25°C. When needed, 13 N NaOH or concentrated H 2 S04 was used to adjust the pH. The assay solution was stored at -22°C for up to 1 month.
Assay
Serum (1-10 µL) was incubated with 490 µL of assay solution containing 5 mM Hip-His-Leu in 0.4 M sodium borate buffer, pH 8.3, and 0.9 M NaCl for 15 minutes at 37°C. The reaction was stopped by the addition of 1.2 ml of 0.34 N NaOH. The product, His Leu, was measured fluorometrically (365 nm excita tion and 495 emission, Aminco Model J4-7461 fluoro monitor, American Instrument Co., Silver Springs, MD) after the addition of 100 µL of o-phthaldialde hyde (20 mg/ml) in methanol, which was followed 10 minutes later by the addition of 200 µL of 3 N HCl and centrifugation in a clinical centrifuge at 800 g for 5 minutes at room temperature. Blanks (T0) were pre pared by reversing the order of the addition of enzyme and NaOH. All measurements were made in duplicate.
The relative fluorescence of the blank was 0.2 to 0.3 compared with 10.0 to 30.00 obtained for rat serum samples. The T0 blanks could be used because the relative fluorescence of serum (without substrate) or substrate (without serum) was constant under the con ditions of the assay. Fifty tubes (25 samples) were assayed at approximately the same time with a 15-second interval between additions.
Solutions of His-Leu (1-30 µM) were prepared dai ly as described for the substrate solution from stock solutions of known concentration (amino acid analy sis), and standard curves were obtained daily. There was a linear relationship between relative fluorescence and His-Leu concentration. The relative fluorescence of free histidine and free leucine was 5% and < 0.05%, respectively, of that of His-Leu. The pres ence of 10 µL of rat or human serum did not change the slope of the His-Leu standard curve. When assays were carried out in potassium phosphate buffer con taining different amounts of NaCl, standard solutions of His-Leu were prepared in a solution appropriate for the assay and run in parallel. The assay that used PB9• 1 0 was carried out as described for human serum by Friedland and Silverstein. The effect of BPP51 and BPP91 on ACE activity was determined after preincubating IO µL of rat serum with 10 µL of the peptide for 7 .5 minutes and then assaying the sample in 500 µL of 5 mM Hip-His-Leu in BB. The concentrations of BPP51 and BPP91 in the assay were 6.6 µM and 0.8 M respectively. The effect of added chloride ion was determined by incubating 10 µ.L of rat serum (not dialyzed) with 0.490 ml of 5 mM Hip-His-Leu in 0.4 M sodium borate buffer, pH 8.3.
Measurement of Dipeptidase Activity
The conditions for the measurement of dipeptidase activity in BB or PB are given in Table 2 . The reaction was stopped by adding an equal volume of 0.2 M sodium citrate buffer, pH 2.2, containing 0.4 N HCl and 30% polyethylene glycol, and the sample was fur ther diluted to 2.0 ml with 0.2 M sodium citrate buffer, pH 2.2, containing 15% polyethylene glycol. Aliquots (0.900 ml) were applied directly to an amino acid analyzer. Full-scale deflection of the amino acid ana lyzer recorder was obtained with 5 nmol histidine and 6 nmol leucine. Duplicate measurements varied by 8% or less. The levels of histidine (about I nmol/ I 0 µ.L of plasma) and leucine (about 2 nmol/ I 0 µ.L of plasma) did not increase with autolysis under the assay condi tions.
Direct Determination of the Dipeptidase Subestimation Error
The ACE assay was carried out as described; four tubes each were used for the assay and control (T0). At the end of the 15-minute incubation, half the tubes were processed for the ftuorometric determination of His-Leu and the remaining tubes were processed for amino acid analysis as described for the measurement of dipeptidase activity. The T0 blanks were subtracted. The subestimation error, His/(His + His-Leu) x 100, thus provides a direct measurement of the effect of dipeptidase activity under the actual assay conditions.
Michaelis-Menten Constants
The concentrations of Hip-His-Leu (ACE) used for measurements in BB were 0.2, 0.3, 0.5, 0.75, 1.0, I .5, and 2.0 mM and 0.5, I .0, 2.0, 5.0, and 13.0 mM for PB. His-Leu (dipeptidase activity) was used in concentrations of 0.25, 0.5, 1.25, and 2.5 mM for BB and in concentrations of 0.0625, 1. 125, 0.25, 0.5, and I .0 mM for PB. The incubation times were 5, IO, and 15 minutes for Hip-His-Leu in both buffers and His Leu in PB. The assays of His-Leu in BB were carried out for I 5, 20, and 45 minutes. The hydrolysis of Hip His-Leu was measured by ftuorometry; the hydrolysis of His-Leu was measured by amino acid analysis. The assays were carried out with JO µ.L of serum (pool derived from the serum of 5 rats, which had been stored for 7-10 days) in a final volume of 250 µ.L. All measurements were carried out in duplicate, and the T0 blank was subtracted. The Km and Y mu were calculated by the method of Wilkinson14 from the velocity of the reaction, which was constant for all time points. The substrate. 5 mM Hip-His-Leu, was incubated with 10 µ.L of rat or human serum in 0.25 ml of buffer, pH 8 3, at 37°C for 15 minutes. His-Leu was measured by fluorometry and His by amino acid analysis.
Subestimation error(%) = H1s / (His + His-Leu) x 100. ACE = angiotensin-converting enzyme. 
Results
Dipeptidase Problem
The ftuorometric measurement of the hydrolysis of Hip-His-Leu is sensitive to a subestimation error caused by the dipeptidase hydrolysis of His-Leu be cause the relative fluorescences of His and Leu are 5% and <0.05% of His-Leu. Table 1 shows that with the PB assay medium normally used to measure human serum ACE (0. 1 M potassium phosphate buffer, pH 8.3, containing 0.3 M NaCl), the subestimation error is small (3.3%) for a representative pool of human serum but large (23.2%) for rat serum. Increasing buff er and NaCl concentration decreased the error and in creased the ACE activity of serum from both species.
Effect of Assay Conditions on Dipeptidase and
Angiotensin-Converting Enzyme Activity
The data in Table 2 , normalized to the rate of hy drolysis obtained with PB (100%), show that the di peptidase activity was lower in borate than in phos phate buffer and that, of the combinations tested, 0.4 M buffer plus 0.9 M NaCl gave the maximum reduc tion of dipeptidase activity. It should be noted that these are initial rates of hydrolysis of His-Leu and not ACE subestimation errors. Figure 1 shows the effect of varying NaCl and buffer concentrations on rat and human ACE activity, which has not been corrected for the dipeptidase subestimation error. In the presence of 0. 1 M sodium borate or 0. 1 M potassium phosphate, ACE activity increased with NaCl concentration and reached a maximum above 0.7 to 0.9 M NaCl with a decline demonstrable at 1.2 M NaCl in the presence of 0. 1 M sodium borate. In the presence of 0.3 M NaCl, increasing concentrations of borate up to 0.4 M acti vated ACE activity of both species, whereas phosphate inhibited it at concentrations greater than 0.25 M. Re sults for other serum pools in Table 3 complement the data in Figure 1 and show that maximal activation of Comparison of the Effects of PB and BB Figure 2 (top panel) shows that the BB assay medi um (speckled bars) inhibited rat serum dipeptidase ac tivity 80 to 85% in comparison to the PB assay medium (open bars) for both Pools I and 2, which were selected for low and high ACE activity. Dipeptidase activity decreased about 50% after the first day of storage at -20°C and was essentially constant for the following 24 days. Figure 2 (middle panel) shows that the subestima tion error was constant and about 3 to 5% under BB conditions. In contrast, for the PB medium the error was 16% (Pool I) and 40% (Pool 2) on Day 0 and was poo l and storage-time dependent. Figure 2 (bottom panel) compares the measured uncorr e cted ACE activ ity with the corrected activity (black area Ofl top of each bar) as a function of stor&ge time. Rat ACE activ ity was about three times higher in BB than in PB and was essentially constant when measured on Days 0, 6, and 30 in both assay media.
The Michaelis-Menten constants (Table 4) showed that the reduction of dipeptidase activity by BB was achieved by increasing Km threefold and decreasing Km from 3.0 to I. IO mM contributed much less to the increase in measured activity because 5 mM substrate is used in the assay.
As the concentration of His-Leu in the assay is well below the Km of the di peptidase activity, carrying out the assay in a larger volume but with the same amount of serum and same substrate concentration should re duce the subestimation error in proportion to the vol ume increase. Indeed, increasing the incubation vol ume of BB from 250 µL to 500 µL reduced the error for Pools 1 and 2 by a little less than 50% (from 3.0% and 4.3% to 1.8% and 2.3% respectively). As expect ed, the corrected ACE activity was the same in both assay volumes. The error in PB was also reduced, from 14.8% and 40.0% to 8.9% and 24% respectively, which, however, is unacceptably high. A surprising and as yet unexplained result was that the corrected ACE activity in PB was reduced by about 22% in the larger reaction volume.
Properties and Specificity of the Assay of Rat Serum
Angiotensin-Converting Enzyme Borate Buffer
The pH optimum for the hydrolysis of 5 mM Hip His-Leu by rat serum in BB was near 8. ACE activity subestimation error was determined as described in Methods under the conditions given in Table I . drolysis and 1 to 10 µL of raJ serum. Under the condi tions proposed for the assay (i.e., up to 10 µL of rat serum in 500 µL of incubation volume for 15 minutes at 37°C) most sera liberated 10 to 40 nmol His-Leu, the T0 blank was :s 3% of the product obtained in a typical assay, and the di peptidase error was :s 3%. The inter assay and intraassay coefficients of variation were 3.9% and 2.2% respectively. The specificity of the hydrolysis of Hip-His-Leu as a measure of ACE activity was indirectly demonstrable by the 96% inhibition of activity when chloride was not added to the substrate assay solution and by the 97% inhibition obtained by the Bothrops venom ACE inhibitors BPP�. (6.6 µM) and BPP.,. (0.8 µM).
Quantitative Comparison of Serum Angiotensin
Converting Enzyme Activity Measured with Hip-His-Leu and Angiotensin I
We measured the conversion of ANG I by serum by using HPLC to determine the levels of ANG II, as illustrated in Figure 3 (p. 250) , and by fluorescence measurement of His-Leu. The HPLC elution diagram obtained for a rat serum hydrolysate of ANG I is shown in Figure 3 (bottom) . The peak eluted at 5.6 minutes corresponds to synthetic ANG II (Figure 3, top) . The peak height of ANG II was used to determine the extent of hydrolysis of ANG I because His-Leu was eluted near V0 and other ultraviolet-positive material eluting in this position interfered with the quantitation of His-Leu. Table 5 shows the data for human and rat serum acting on ANG II and Hip-His-Leu under assay condi tions appropriate for each substrate. Both products of hydrolysis of ANG I were measured: ANG II by HPLC Ten µ.L of serum was incubated with 0. 25 mM ANG I in 0. 24 ml ofO. I M sodium phosphate buffer, pH 7 .5, containing 30 mM NaCl for 60 minutes at 37°C. When Hip-His-Leu was the substrate, IO µ.L of serum was incubated with 0.490 µ.L of 5 mM Hip-His-Leu in 0.4 M sodium borate buffer, pH 8.3, containing 0.9 M NaCl for 15 minutes at 37°C.
The ratios of rates of hydrolysis by serum-converting enzyme are identified in Columns I to 3 by the substrate, with the method of detection given in parentheses. Fluorometry (F) was used to detect His-Leu released from Hip-His-Leu and angiotensin I (ANG I), and high-performance liquid chromatography (HPLC) was used to detect angiotensin II (ANG II) released from ANG I. His-Leu was much higher than that of ANG II, and the serum samples were different, the ratios of the rates of hydrolysis of the substrates were essentially constant when calculated on the basis of the hydrolysis of ANG I with either ANG II (12.7 ± 0.91, r = 0.98, p < 0.05, Column 2) or His-Leu (13.4 ± 0.91, r = 0.99, p < 0.05, Column 3). Essentially constant ratios of the rates of hydrolysis of the two substrates also were obtained for rat serum when ANG I hydrolysis was measured by HPLC (18.4 ± 0.88, r = 0.99, p < 0.05, Column 2). Stoichiometry for the release of both ANG I products was not demonstrable for rat serum (0.76 ± 0.03, Column 1), presumably because rat dipeptidase activity hydrolyzed about 20% of the His Leu product. This finding can be explained by the fact that the assay was carried out in 0.1 M sodium phos phate buffer, pH 7.5, containing 30 mM NaCl, which is usually employed for ANG I hydrolysis16 but which also had high levels of dipeptidase activity because of the low concentrations of salt and buffer (data not presented). These data show the excellent correlation between the hydrolysis of both substrates by human and rat serum and provides quantitative evidence for the validity of using Hip-His-Leu to measure ACE activity in this complex mixture.
Comparison of the Measurement of Angiotensin
Converting Enzyme Activity in Rat Serum and Plasma
Serum was chosen for detailed study because pre liminary experiments indicated that the level of dipep tidase activity in serum was up to 30% higher than in plasma. After defining the appropriate assay condi tions for rat serum, the behavior of the assay for rat plasma was checked. As documented here for rat se rum, rat plasma ACE activity was increased in BB and had a constant velocity that was linear with enzyme concentration. The� for Hip-His-Leu was the same for both plasma and serum activity, as was the inhibi tion demonstrable for BPP5., BPP9,, and in the absence of added chloride ion. When the ACE activity and subestimation error for pools of plasma and serum prepared from the blood of the same rats were assayed in BB and PB, the specific activity of plasma was approximately IO% lower than serum for both buffers and the subestimation error was lower in plasma (7.3%) than in serum (11.7%) when PB was used, but was still of unacceptably high levels. In BB plasma and serum had a low (< 2.5%) subestimation error.
These results indicate that the BB assay conditions are suitable for the measurement of ACE activity in rat plasma as well as rat serum.
Discuss ion
The most serious limitation of the fluorometric method for the measurement of ACE in serum, plas ma, or tissue extracts is the possible subestimation error caused by dipeptidase hydrolysis of His-Leu or other dipeptides released from amino-terminal blocked tripeptide substrates. Indeed, when we mea sured rat serum or plasma ACE activity using Hip-His Leu in 0.1 M potassium phosphate, 0.3 M NaCl, which is one of the most commonly used media for measuring ACE activity in serum and tissue, u. 9· 10· 16 direct measurement showed that the rat serum di pepti dase activity led to subestimation errors of IO% to 40% depending on serum sample, storage time, and the extent of hydrolysis. This problem does not arise when hippuric acid is measured by spectrophotometry or HPLC after extraction or by radioactivity. Because of the sensitivity, accuracy, reproducibility, speed, and economy of the ftuorometric method, however, we sought to minimize this error in order to apply the method for the serial measurement of rat serum and plasma ACE in experimental models of hypertension. The difference between the behavior of rat and human serum indicates that species differences -in this case the levels of serum and plasma dipeptidase activitymust be considered when applying assays developed and validated for other species.
The extent of the ACE activation by chloride de pends on pH, substrate, and buffer. 11-20 At pH 8.3, ACE activity is maximum at about 1.0 M NaCl, which reflects the pH-dependent increase of the dissociation constant, K., of chloride ion, thereby increasing V 111"-' and decreasing Km . 1 7· 1 9
The higher activity of ACE in BB compared with that in PB has been observed. 2 1 · 22 Figure 1 shows that there was a moderate concentration-dependent activa tion by borate that was demonstrable even in the pres ence of a near optimal NaCl concentration (0.9 M) at pH 8.3 (see Table 3 ). Ionic strength has been suggest ed as an explanation for activation by sodium sulfate18; however, Bunning and Riordan1 7 and Shapiro and col leagues19 have shown that the activation achieved by increasing the concentration of some anions appears to be a specific effect and is not due only to ionic strength. In contrast to borate, increasing concentra tions of phosphate in the presence of 0.3 M NaCl increased and then decreased both human and rat se rum ACE activity ( Figure 1 ). The data in Table 3 show that even at maximal NaCl concentration (0. 9 M) there was a 52% reduction of ACE activity when phosphate concentration was increased from 0. Km (data not presented). The biphasic effect of phos phate ( Figure I ) and the data given in Table 3 showing that increasing phosphate concentration overcame the chloride activation may be interpreted in terms of phosphate competing with chloride at one or more lysyl-£-amino groups. 2 6· 2 7
The inhibition of serum dipeptidase activity by in creasing NaCl concentration, for which borate was more effective than phosphate (Tables 2 and 4), ap pears to be an ionic strength effect that cannot be analyzed in more detail because of the scarcity of data in the literature.
The use of synthetic substrates, such as Hip-HisLeu, rather than the physiological substrate ANG I for the measurement of ACE activity in complex mixtures such as serum, plasma, or tissue extracts has been validated with purified enzyme and with inhibition data for the complex mixtures of the type provided here (BPP5,, BPP'h, minus chloride). Friedland and Silverstein28 demonstrated parallelism between His Leu release from ANG I and Hip-His-Leu by human serum, which was determined ftuorometrically. In the present study we have addressed this question by pro viding both quantitative data and the positive identifi cation of ANG II. We demonstrated the stoichiometric release of ANG II and His-Leu by human serum. The lower recovery of His-Leu in rat serum hydrolysates was due to dipeptidase activity in 0. 1 M sodium phos phate buffer, pH 7.5, 30 mM NaCl (conditions select ed for optimal ANG I hydrolysis). 16 Furthermore, our data showed a close correlation between ANG I and Hip-His-Leu hydrolysis for several samples of rat and human serum. These data provide a quantitative and specific validation for the use of Hip-His-Leu to mea sure ACE activity in complex mixtures such as rat and human serum.
In spite of the almost tenfold differences in the rate of hydrolysis (nmol min-1 ml-1) of Hip-His-Leu by rat and human serum, the hydrolysis of the physiological ly important substrate ANG I was essentially the same, 4.57 ± 0.25 versus 3.77 ± 1.37 nmol min-1 m1-1 for rat and human serum respectively (see Table 5 ). Con roy and colleagues2 9 showed that purified rabbit and dog lung ACE have different Km and V max for Hip-His
Leu hydrolysis but that these constants are essentially the same for ANG I. These considerations emphasize the problem of comparing levels of ACE activity be tween species when Hip-His-Leu or other synthetic substrates are used. 2 9 The conservation of specific ac tivity for the physiologically important substrate, in contrast to differences observed for synthetic sub strates, suggests subtle differences among ACE from different species, and this should be considered when interpreting differences in the activity of synthetic or natural ACE inhibitors.
Our results suggest the efficacy of the use of 0.4 M sodium borate buffer, pH 8.3, containing 0.9 M NaCl for the ftuorometric determination of rat serum and plasma and human ACE. It is most likely that this assay solution can be used for tissue as well, but before being applied to other species and tissues the extent of the possible interference by dipeptidase activity must be evaluated. We found that this assay, which requires five additions to the same tube, centrifugation, and a ftuorometric measurement, can be used to process 25 samples in duplicate in less than 2 hours. It also ap peared to be highly sensitive, simple, rapid, and much less complicated than other methods in current use, which require organic solvent extraction, isotope counting30 or HPLC31 for monitoring Hip-His-Leu hy drolysis. We found that the sensitivity of the assay could be increased tenfold by increasing the incubation time and reducing the volumes of reagents used for the ftuorometric assay.
